UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000032840
Receipt number R000034165
Scientific Title Lacrimal sac massage for congenital nasolacrimal duct obstruction: a multi-center randomized controlled trial
Date of disclosure of the study information 2018/06/01
Last modified on 2024/04/02 21:39:20

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Lacrimal sac massage for congenital nasolacrimal duct obstruction: a multi-center randomized controlled trial

Acronym

Lacrimal sac massage for congenital nasolacrimal duct obstruction: a multi-center RCT

Scientific Title

Lacrimal sac massage for congenital nasolacrimal duct obstruction: a multi-center randomized controlled trial

Scientific Title:Acronym

Lacrimal sac massage for congenital nasolacrimal duct obstruction: a multi-center RCT

Region

Japan


Condition

Condition

Congenital nasolacrimal duct obstruction

Classification by specialty

Ophthalmology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the effectiveness and safety of the Lacrimal sac massage for congenital nasolacrimal duct obstruction

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Cure rate at 1 month

Key secondary outcomes

Duration of treatment until cure (up to 3 month), Number of lacrimal sac massage until cure, drop-out rate, rate of surgical intervention, and safety


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

No treatment

Stratification

YES

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine Maneuver

Interventions/Control_1

Lacrimal sac massage twice a day (10 times each) by trained family with antibiotic eye drops three times a day

Interventions/Control_2

Antibiotic eye drops three times a day

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

3 months-old <=

Age-upper limit

12 months-old >

Gender

Male and Female

Key inclusion criteria

(1) Patients from three months to twelve months who are diagnosed with congenital nasolacrimal duct obstruction.
(2) Patients whose legally acceptable representative provided voluntary written consent for participation in this study

Key exclusion criteria

1. Patients with congenital malformation, mental retardation, and facial anomalies.
2. Patients who have had a history of perinatal abnormality.
3. Patients with diseases such as keratitis and epiblepharon that may lead epiphora and eye discharge.
4. Patients who have had a history of surgery on lacrimal apparatus.
5. Patients who have had a history of facial injury that may affect lacrimal duct.
6.Patients who have had a history of infectious disease such as epidemic keratoconjunctivitis and herpes palpebrae that may lead lacrimal duct abnormality.
7. Patients with atresia puncti lacrimalis or lacrimal fistula.
8.Patients with congenital dacryocystocele or acute dacryocystitis.
9. Patients with severe blepharitis.
10. Patients who are considered inadequate to participate in this study by the medical doctor.

Target sample size

105


Research contact person

Name of lead principal investigator

1st name Masaki
Middle name
Last name Takeuchi

Organization

Yokohama City University

Division name

Ophthalmology

Zip code

2360004

Address

3-9, Fukuura, Kanazawa-ku, Yokohama, Kanagawa

TEL

045-787-2683

Email

takeuchi@yokohama-cu.ac.jp


Public contact

Name of contact person

1st name Masaki
Middle name
Last name Takeuchi

Organization

Yokohama City University

Division name

Ophthalmology

Zip code

2360004

Address

3-9, Fukuura, Kanazawa-ku, Yokohama, Kanagawa

TEL

0457872800

Homepage URL


Email

takeuchi@yokohama-cu.ac.jp


Sponsor or person

Institute

Department of Ophthalmology, Yokohama City University

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor

Kanagawa Children's Medical Center

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Yokohama City Univ. IRB

Address

3-9 Fukuura, Kanazawa-ku, Yokohama

Tel

0457872800

Email

rinri@yokohama-cu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 06 Month 01 Day


Related information

URL releasing protocol

It will be piblished with the research paper.

Publication of results

Unpublished


Result

URL related to results and publications

The results of this study will be published in the research paper being submitted.

Number of participants that the trial has enrolled

102

Results

The results of this study are described in the research paper being submitted.

Results date posted

2023 Year 12 Month 05 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

The results of this study are described in the research paper being submitted.

Participant flow

The results of this study are described in the research paper being submitted.

Adverse events

No adverse event was observed during the study period.

Outcome measures

The primary endpoint was a comparison of the 1-month resolution rate in the massage and non-massage groups.

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2018 Year 05 Month 18 Day

Date of IRB

2018 Year 05 Month 14 Day

Anticipated trial start date

2018 Year 06 Month 04 Day

Last follow-up date

2022 Year 08 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2018 Year 06 Month 01 Day

Last modified on

2024 Year 04 Month 02 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034165


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name